| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2014-02-17 | CoStim Pharmaceuticals (USA) | Novartis (Switzerland) | undisclosed | Cancer - Oncology |
| 2014-02-12 | ALK (Denmark) | Bio-Medical Services (USA) | undisclosed | Veterinary medicine |
| 2014-02-11 | Affinium's clinical and preclinical assets and technology platform (Canada) | Debiopharm (Switzerland) | undisclosed | Infectious diseases |
| 2014-02-11 | Galderma (Switzerland) | Nestlé (Switzerland) | €3.1 billion | Aesthetic medicine Dermatological diseases |
| 2014-02-04 | Cornerstone Therapeutics (USA - NC) | Chiesi Farmaceutici (Italy) | $ 70 million | specialty pharma |
| 2014-01-30 | Accelrys (USA) | Dassault Systèmes (France) | $750 million (€553.5 million) | |
| 2014-01-27 | Trianta Immunotherapies (Germany) | Medigene (Germany) | up to € 5.875 million | Cancer - Oncology - Immunotherapy |
| 2014-01-23 | Tigenix' s cell therapy production facility (Belgium) | PharmaCell (The Netherlands) | €5.75 million | Cell therapy CMO |
| 2014-01-21 | NuPathe (USA) | Teva (Israel) | ||
| 2014-01-16 | IDmyk (France) | Eurofins Scientific (Luxembourg) | undisclosed | |
| 2014-01-13 | 4-Antibody (Switzerland) | Agenus (USA) | $10 million and up to $40 million based on the combined company achieving certain milestones | Drug development |
| 2014-01-09 | Discovery and Development Solutions (DDS) business of Merck Millipore | Eurofins Scientific (Luxembourg) | undisclosed | drug development |
| 2014-01-06 | Okapi Sciences (Belgium) | Aratana Therapeutics (USA) | undisclosed | Veterinary medicine |
| 2014-01-02 | CeeTox (USA) | Cyprotex (UK) | £0.63 million (€0.76 million) | CRO |
| 2013-12-23 | ATMI LifeSciences (USA) | Pall Corporation (USA) | $185 million (€ 135.2 million) | bioprocess systems |
| 2013-12-19 | BMS' diabetes business | AstraZeneca (UK) | up to $4.1 billion (€3 billion) | diabetes metabolic diseases |
| 2013-12-19 | Gentium (Italy) | Jazz Pharmaceuticals (Ireland) | $1 billion | Rare diseases |
| 2013-12-09 | Biocitech (France) | Caisse des Depots (France) | ||
| 2013-12-08 | Given Imaging (Israel) | Covidien (Ireland) | $860 million | diagnostic |
| 2013-12-06 | Eupharmed (Italy) | Nicox (France) | up to €5.9 million | Ophtalmic industry |
